KYNZETIX Trademark

Trademark Overview

On Thursday, July 7, 2022, a trademark application was filed for KYNZETIX with the United States Patent and Trademark Office. The USPTO has given the KYNZETIX trademark a serial number of 97493489. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 19, 2024. This trademark is owned by PTC Therapeutics, Inc.. The KYNZETIX trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of genetic diseases and disorders
kynzetix

General Information

Serial Number97493489
Word MarkKYNZETIX
Filing DateThursday, July 7, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 23, 2023

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of genetic diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 26, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePTC Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth Plainfield, NJ 07080
Party NamePTC Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth Plainfield, NJ 07080

Trademark Events

Event DateEvent Description
Monday, July 11, 2022NEW APPLICATION ENTERED
Tuesday, July 26, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 20, 2023ASSIGNED TO EXAMINER
Thursday, April 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 3, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 23, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 23, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, June 9, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 9, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 9, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 18, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, January 18, 2024SOU EXTENSION 1 FILED
Monday, February 19, 2024ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 20, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, April 18, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 18, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 18, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 19, 2024PETITION TO REVIVE-GRANTED
Friday, April 19, 2024NOTICE OF REVIVAL - E-MAILED
Friday, April 19, 2024TEAS PETITION TO REVIVE RECEIVED
Friday, April 19, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Friday, April 19, 2024TEAS PETITION TO REVIVE RECEIVED
Monday, June 24, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 26, 2024SOU EXTENSION 1 GRANTED
Wednesday, June 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 19, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, August 19, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

kynzetix diseases disorders genetic treatment preparations pharmaceutical